Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -3.202\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CCOC(=O)c1ccc(NC(=O)C2CCCN(c3cnccn3)C2)cc1
[b] Cc1nn(Cc2cccc(Oc3ccccc3)c2)c(C)c1NC(=O)NC12CC3CC(CC(C3)C1)C2
Answer: a. CCOC(=O)c1ccc(NC(=O)C2CCCN(c3cnccn3)C2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)c1ccc(NC(=O)C2CCCN(c3cnccn3)C2)cc1
CCOC(=O)c1ccc(NC(=O)C2CCCN(c3cnccn3)C2)cc1
ethyl4-[(1-pyrazin-2-ylpiperidine-3-carbonyl)amino]benzoate